Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 18/20 | 0.61 |
| ▸ | ECE1 | P42892 | 1/20 | 0.55 |
| ▸ | GHSR | Q92847 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3497693 | 0.93 | KISS1R (0.62) | KISS1RECE1GHSR | |
| SCHEMBL21851621 | 0.93 | KISS1R (0.65) | KISS1RECE1 | |
| SCHEMBL29872703 | 0.92 | KISS1R (0.64) | KISS1RECE1GHSR | |
| SCHEMBL31718765 | 0.92 | KISS1R (0.67) | KISS1RECE1 | |
| SCHEMBL29851826 | 0.91 | KISS1R (0.64) | KISS1RECE1 | |
| SCHEMBL29657322 | 0.90 | KISS1R (0.65) | KISS1RECE1 | |
| SCHEMBL14685608 | 0.90 | KISS1R (0.65) | KISS1RECE1 | |
| SCHEMBL29871835 | 0.87 | KISS1R (0.60) | KISS1RGHSR | |
| SCHEMBL15896470 | 0.86 | KISS1R (0.72) | KISS1R | |
| SCHEMBL31718762 | 0.86 | KISS1R (0.78) | KISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3650464-B1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | SHANGPHARMA INNOVATION INC (US) | 2025-11-05 | — | — | EP | disclosed |
| US-11807660-B2 | Peptide compound and application thereof, and composition containing peptide compound | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2023-11-07 | — | — | US | disclosed |
| US-11427615-B2 | Peptide compound and application thereof, and composition containing peptide compound | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2022-08-30 | — | — | US | disclosed |
| US-20220213142-A1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2022-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11427615-B2 | Peptide compound and application thereof, and composition containing peptide compound | KISS1R, VIP, NPY1R | KISS1R 1/4885ECE1 728/4885GHSR 56/4885 |
| US-20220213142-A1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | KISS1R, VIP, SSTR3 | KISS1R 1/4885ECE1 996/4885GHSR 35/4885 |
| US-11807660-B2 | Peptide compound and application thereof, and composition containing peptide compound | KISS1R, VIP, SSTR3 | KISS1R 1/4885ECE1 996/4885GHSR 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.